サワイグループホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/03/18 | 4,500 | 4,530 | 4,450 | 4,475 | -80 | -1.8% | 221,700 |
2022/03/17 | 4,570 | 4,585 | 4,525 | 4,555 | -15 | -0.3% | 81,700 |
2022/03/16 | 4,640 | 4,650 | 4,570 | 4,570 | -25 | -0.5% | 71,500 |
2022/03/15 | 4,520 | 4,615 | 4,505 | 4,595 | +85 | +1.9% | 81,700 |
2022/03/14 | 4,460 | 4,535 | 4,425 | 4,510 | +45 | +1% | 87,700 |
2022/03/11 | 4,380 | 4,490 | 4,380 | 4,465 | -55 | -1.2% | 119,200 |
2022/03/10 | 4,425 | 4,530 | 4,395 | 4,520 | +160 | +3.7% | 107,900 |
2022/03/09 | 4,280 | 4,385 | 4,270 | 4,360 | +75 | +1.8% | 108,500 |
2022/03/08 | 4,270 | 4,350 | 4,270 | 4,285 | -5 | -0.1% | 121,000 |
2022/03/07 | 4,350 | 4,355 | 4,275 | 4,290 | -90 | -2.1% | 78,200 |
2022/03/04 | 4,460 | 4,470 | 4,370 | 4,380 | -75 | -1.7% | 83,300 |
2022/03/03 | 4,435 | 4,490 | 4,425 | 4,455 | +60 | +1.4% | 39,100 |
2022/03/02 | 4,440 | 4,490 | 4,390 | 4,395 | -85 | -1.9% | 84,200 |
2022/03/01 | 4,460 | 4,515 | 4,430 | 4,480 | -85 | -1.9% | 108,600 |
2022/02/28 | 4,455 | 4,570 | 4,435 | 4,565 | +145 | +3.3% | 96,300 |
2022/02/25 | 4,450 | 4,450 | 4,385 | 4,420 | -30 | -0.7% | 59,800 |
2022/02/24 | 4,460 | 4,470 | 4,385 | 4,450 | +60 | +1.4% | 92,800 |
2022/02/22 | 4,410 | 4,420 | 4,380 | 4,390 | -35 | -0.8% | 64,100 |
2022/02/21 | 4,460 | 4,480 | 4,415 | 4,425 | -105 | -2.3% | 43,900 |
2022/02/18 | 4,405 | 4,535 | 4,395 | 4,530 | +80 | +1.8% | 98,700 |
2022/02/17 | 4,475 | 4,535 | 4,425 | 4,450 | -50 | -1.1% | 143,500 |
2022/02/16 | 4,455 | 4,540 | 4,430 | 4,500 | -45 | -1% | 141,600 |
2022/02/15 | 4,465 | 4,610 | 4,450 | 4,545 | -60 | -1.3% | 160,400 |
2022/02/14 | 4,575 | 4,625 | 4,560 | 4,605 | +5 | +0.1% | 80,700 |
2022/02/10 | 4,580 | 4,630 | 4,570 | 4,600 | +30 | +0.7% | 100,400 |
2022/02/09 | 4,545 | 4,575 | 4,500 | 4,570 | +60 | +1.3% | 82,700 |
2022/02/08 | 4,510 | 4,540 | 4,505 | 4,510 | +5 | +0.1% | 46,800 |
2022/02/07 | 4,470 | 4,510 | 4,450 | 4,505 | +15 | +0.3% | 49,300 |
2022/02/04 | 4,465 | 4,510 | 4,440 | 4,490 | +45 | +1% | 80,500 |
2022/02/03 | 4,385 | 4,475 | 4,375 | 4,445 | +55 | +1.3% | 68,700 |
2022/02/02 | 4,295 | 4,395 | 4,290 | 4,390 | +90 | +2.1% | 114,300 |
2022/02/01 | 4,230 | 4,320 | 4,230 | 4,300 | -35 | -0.8% | 123,000 |
2022/01/31 | 4,340 | 4,360 | 4,305 | 4,335 | +5 | +0.1% | 110,400 |
2022/01/28 | 4,360 | 4,385 | 4,320 | 4,330 | +5 | +0.1% | 66,800 |
2022/01/27 | 4,375 | 4,405 | 4,305 | 4,325 | -40 | -0.9% | 74,700 |
2022/01/26 | 4,410 | 4,420 | 4,360 | 4,365 | -45 | -1% | 51,800 |
2022/01/25 | 4,360 | 4,415 | 4,345 | 4,410 | -10 | -0.2% | 47,100 |
2022/01/24 | 4,355 | 4,420 | 4,335 | 4,420 | +55 | +1.3% | 85,300 |
2022/01/21 | 4,280 | 4,375 | 4,260 | 4,365 | +50 | +1.2% | 81,200 |
2022/01/20 | 4,280 | 4,360 | 4,280 | 4,315 | -5 | -0.1% | 102,100 |
2022/01/19 | 4,345 | 4,360 | 4,295 | 4,320 | -25 | -0.6% | 91,800 |
2022/01/18 | 4,415 | 4,430 | 4,340 | 4,345 | -70 | -1.6% | 85,300 |
2022/01/17 | 4,400 | 4,440 | 4,385 | 4,415 | +75 | +1.7% | 60,500 |
2022/01/14 | 4,340 | 4,360 | 4,305 | 4,340 | -60 | -1.4% | 123,500 |
2022/01/13 | 4,470 | 4,470 | 4,395 | 4,400 | -80 | -1.8% | 87,900 |
2022/01/12 | 4,440 | 4,495 | 4,440 | 4,480 | +25 | +0.6% | 75,900 |
2022/01/11 | 4,450 | 4,520 | 4,400 | 4,455 | -25 | -0.6% | 122,400 |
2022/01/07 | 4,455 | 4,510 | 4,455 | 4,480 | +15 | +0.3% | 57,700 |
2022/01/06 | 4,490 | 4,505 | 4,450 | 4,465 | -25 | -0.6% | 109,700 |
2022/01/05 | 4,490 | 4,505 | 4,450 | 4,490 | +35 | +0.8% | 75,400 |
651~
700
件表示中 / 886件
類似銘柄と比較する
現在ご覧いただいている「サワイGHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サワイGHD | 191,800円 | +4.0% | +25.4% | 2.76% | 8.86倍 | 1.17倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
ペプチド | 273,700円 | +56.7% | +357.2% | 0.00% | 25.34倍 | 6.04倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 395,800円 | +3.9% | -3.3% | 3.13% | 9.19倍 | 1.21倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 62,900円 | +7.5% | - | 0.00% | - | 2.19倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
科研薬 | 435,000円 | +22.8% | +113.0% | 4.37% | 11.61倍 | 1.07倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム